Potential roles of serum ATPase and AMPase in predicting diagnosis of colorectal cancer patients

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin. 2021 May;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin. 2016 Mar-Apr;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Ladabaum U, Dominitz JA, Kahi C, et al. Strategies for colorectal cancer screening[J]. Gastroenterology. 2020 Jan;158(2):418–432.
   PubMed Web of Science ®Google Scholar
• Li H, Lin J, Xiao Y, et al. Colorectal cancer detected by machine learning models using conventional laboratory test data[J]. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211058352.
   Web of Science ®Google Scholar
• Kepp O, Loos F, Liu P, et al. Extracellular nucleosides and nucleotides as immunomodulators[J]. Immunol Rev. 2017 Nov;280(1):83–92.
   PubMed Web of Science ®Google Scholar
• Faas MM, Sáez T, de Vos P. Extracellular ATP and adenosine: the Yin and Yang in immune responses?[J]. Mol Aspects Med. 2017 Jun;55:9–19.
   PubMed Web of Science ®Google Scholar
• Borea PA, Gessi S, Merighi S, et al. Pharmacology of adenosine receptors: the state of the art[J]. Physiol Rev. 2018 Jul 1;98(3):1591–1625.
   PubMed Web of Science ®Google Scholar
• de Andrade Mello P, Coutinho-Silva R, Savio LEB. Multifaceted effects of extracellular adenosine triphosphate and adenosine in the tumor-host interaction and therapeutic perspectives[J]. Front Immunol. 2017 Nov 14;8: 1526.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Y, Chu Y, et al. Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma[J]. J Hepatol. 2021 Mar;74(3):627–637.
   PubMed Web of Science ®Google Scholar
• Cai XY, Ni XC, Yi Y, et al. Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection[J]. Medicine (Baltimore). 2016 Oct;95(40):e4989.
   PubMed Web of Science ®Google Scholar
• Vultaggio-Poma V, Sarti AC, Di Virgilio F. Extracellular ATP: a feasible target for cancer therapy[J]. Cells. 2020 Nov 17;9(11):2496.
   PubMed Web of Science ®Google Scholar
• Ma XL, Shen MN, Hu B, et al. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis[J]. J Hematol Oncol. 2019 Apr 11;12(1):37.
   PubMedGoogle Scholar
• Pfaffenzeller MS, Franciosi MLM, Cardoso AM. Purinergic signaling and tumor microenvironment in cervical cancer[J]. Purinergic Signal. 2020 Mar;16(1):123–135.
   PubMed Web of Science ®Google Scholar
• Morandi F, Marimpietri D, Horenstein AL, et al. Microvesicles expressing adenosinergic ectoenzymes and their potential role in modulating bone marrow infiltration by neuroblastoma cells[J]. Oncoimmunology. 2019 Feb 19;8(5):e1574198.
   PubMed Web of Science ®Google Scholar
• Jiang ZG, Wu Y, Csizmadia E, et al. Characterization of circulating microparticle-associated CD39 family ecto-nucleotidases in human plasma[J]. Purinergic Signal. 2014 Dec;10(4):611–618.
   PubMed Web of Science ®Google Scholar
• Sidders B, Zhang P, Goodwin K, et al. Adenosine signaling is prognostic for cancer outcome and has predictive utility for immunotherapeutic response[J]. Clin Cancer Res. 2020 May 1;26(9):2176–2187.
   PubMed Web of Science ®Google Scholar
• Oses JP, Cardoso CM, Germano RA, et al. Soluble NTPDase: an additional system of nucleotide hydrolysis in rat blood serum[J]. Life Sci. 2004 May 14;74(26):3275–3284.
   PubMed Web of Science ®Google Scholar
• Vallon V, Mühlbauer B, Osswald H. Adenosine and kidney function[J]. Physiol Rev. 2006 Jul;86(3):901–940.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Tozzi F, Chen J, et al. Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells[J]. Cancer Res. 2012 Jan 1;72(1):304–314.
   PubMed Web of Science ®Google Scholar
• Park W, Chawla A, O’Reilly EM. Pancreatic cancer: a review. JAMA. 2021 Sep 7;326(9):851–862.
   PubMed Web of Science ®Google Scholar
• Xu Z, Sun J, Mao Y, et al. HIG1 domain family member 1A disrupts proliferation, migration, and invasion of colon adenocarcinoma cells[J]. Bioengineered. 2021 Dec;12(2):10501–10511.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yang X, Wei L, et al. Improved diagnostic value by combining plasma PON1 level with tumor biomarkers in Colorectal Cancer patients[J]. J Cancer. 2020 Sep 17;11(22):6491–6496.
   PubMed Web of Science ®Google Scholar
• Normanno N, Cervantes A, Ciardiello F, et al. The liquid biopsy in the management of colorectal cancer patients: current applications and future scenarios[J]. Cancer Treat Rev. 2018 Nov;70:1–8.
   PubMed Web of Science ®Google Scholar
• You W, Yan L, Cai Z, et al. Clinical significances of positive postoperative serum CEA and post-preoperative CEA increment in stage II and III colorectal cancer: a multicenter retrospective study[J]. Front Oncol. 2020;10:671.
   PubMed Web of Science ®Google Scholar
• Gao Y, Wang J, Zhou Y, et al. Evaluation of serum CEA, CA19-9, CA72-4, CA125 and ferritin as diagnostic markers and factors of clinical parameters for colorectal cancer[J]. Sci Rep. 2018 Feb 9;8(1):2732.
   PubMedGoogle Scholar
• Wilhelmsen M, Christensen IJ, Rasmussen L, et al. Detection of colorectal neoplasia: combination of eight blood-based, cancer-associated protein biomarkers[J]. Int J Cancer. 2017 Mar 15;140(6):1436–1446.
   PubMed Web of Science ®Google Scholar
• Di Virgilio F, Sarti AC, Falzoni S, et al. Extracellular ATP and P2 purinergic signalling in the tumour microenvironment[J]. Nat Rev Cancer. 2018 Oct;18(10):601–618.
   PubMed Web of Science ®Google Scholar
• Gilbert SM, Oliphant CJ, Hassan S, et al. ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival[J]. Oncogene. 2019 Jan;38(2):194–208.
   PubMed Web of Science ®Google Scholar
• Di Virgilio F, Adinolfi E. Extracellular purines, purinergic receptors and tumor growth[J]. Oncogene. 2017 Jan 19;36(3):293–303.
   PubMed Web of Science ®Google Scholar
• Turiello R, Capone M, Giannarelli D, et al. Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy[J]. J Immunother Cancer. 2020 Dec;8(2):e001689.
   PubMed Web of Science ®Google Scholar
• Gupta V, Katiyar S, Singh A, et al. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis[J]. Int J Rheum Dis. 2018 Aug;21(8):1548–1556.
   PubMed Web of Science ®Google Scholar
• Allard B, Longhi MS, Robson SC, et al. The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets[J]. Immunol Rev. 2017 Mar;276(1):121–144.
   PubMed Web of Science ®Google Scholar
• Gardani CFF, Cappellari AR, de Souza JB, et al. Hydrolysis of ATP, ADP, and AMP is increased in blood plasma of prostate cancer patients[J]. Purinergic Signal. 2019 Mar;15(1):95–105.
   PubMed Web of Science ®Google Scholar
• Muñóz-Godínez R, de Lourdes Mora-García M, Weiss-Steider B, et al. Detection of CD39 and a highly glycosylated isoform of soluble CD73 in the plasma of patients with cervical cancer: correlation with disease progression[J]. Mediators Inflamm. 2020;2020:1678780.
   PubMed Web of Science ®Google Scholar
• Morello S, Capone M, Sorrentino C, et al. Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab[J]. J Transl Med. 2017 Dec 4;15(1):244.
   PubMedGoogle Scholar
• He Y, Zhao Y, Nelson DM, et al. NMR-based assay for the ex vivo determination of soluble CD73 activity in serum[J]. Anal Chem. 2020 Nov 3;92(21):14501–14508.
   PubMed Web of Science ®Google Scholar
• Bertoni APS, Bracco PA, de Campos RP, et al. Activity of ecto-5’-nucleotidase (NT5E/CD73) is increased in papillary thyroid carcinoma and its expression is associated with metastatic lymph nodes[J]. Mol Cell Endocrinol. 2019;479:54–60.
   PubMed Web of Science ®Google Scholar
• Ji R, Ji Y, Ma L, et al. Keratin 17 upregulation promotes cell metastasis and angiogenesis in colon adenocarcinoma[J]. Bioengineered. 2021 Dec;12(2):12598–12611.
   PubMed Web of Science ®Google Scholar
• Xie L, Pan Z. Circular RNA circ_0000467 regulates colorectal cancer development via miR-382-5p/EN2 axis[J]. Bioengineered. 2021 Dec;12(1):886–897.
   PubMed Web of Science ®Google Scholar
• Attallah AM, El-Far M, Ibrahim AR, et al. Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1[J]. Br J Biomed Sci. 2018 Jul;75(3):122–127.
   PubMed Web of Science ®Google Scholar